glp 1 drugs and antidepressants Study finds GLP-1 receptor agonist use increases likelihood of antidepressant prescription Ozempic and antidepressants: What to

In a 32-week phase 2 trial investigating the effect of CagriSema on HbA1c in subjects with T2D and BMI 27 kg/m 2 , investigational drug is superior to cagrlintide 2.4 mg alone (-2.2% v -0.9%), but not compared to semaglutide 2.4 mg alone (-1.8%) (75)

A summary of clinical trials to include drug, dosing strategy, sample size, primary outcome measurements, risk reduction, date of publication, and conclusions is found in Table 1 [103,104,105,106,107,108,109,110,111,112]

& Mannucci, E

Furthermore, the small number of recorded events prevented subgroup analyses for individual molecules of the class for each specific malignancy, and separate analyses for different doses for each available drug

It activates the same GLP-1 pathway semaglutide uses, but it also targets glucose-dependent insulinotropic polypeptide (GIP) receptors